Wedge Capital Management L L P Vir Biotechnology, Inc. Transaction History

Wedge Capital Management L L P

  • $5.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023
BUY
$23.2 - $27.29 $2.61 Million - $3.07 Million
112,659 Added 1080.66%
123,084 $3.02 Million
Q1 2023

Apr 11, 2023
BUY
$22.26 - $30.85 $27,223 - $37,729
1,223 Added 13.29%
10,425 $242,000
Q4 2022

Jan 17, 2023
BUY
$19.96 - $28.22 $183,671 - $259,680
9,202 New
9,202 $233,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $991M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Wedge Capital Management L L P Portfolio

Follow Wedge Capital Management L L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

News

Stay updated on Wedge Capital Management L L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email